The management of TFE3-RCC is similar to that of other RCC subtypes and primarily involves surgical resection, targeted therapy, and immunotherapy, with surgical excision serving as the mainstay of treatment for localized disease. The gene discussed is TFE3; the disease is renal cell carcinoma.